nodes	percent_of_prediction	percent_of_DWPC	metapath
Paricalcitol—CYP3A4—Methylprednisolone—psoriatic arthritis	0.0946	0.248	CbGbCtD
Paricalcitol—CYP3A4—Triamcinolone—psoriatic arthritis	0.0717	0.188	CbGbCtD
Paricalcitol—CYP3A4—Betamethasone—psoriatic arthritis	0.0615	0.161	CbGbCtD
Paricalcitol—CYP3A4—Prednisolone—psoriatic arthritis	0.0607	0.159	CbGbCtD
Paricalcitol—CYP3A4—Prednisone—psoriatic arthritis	0.0573	0.15	CbGbCtD
Paricalcitol—CYP3A4—Dexamethasone—psoriatic arthritis	0.0358	0.0937	CbGbCtD
Paricalcitol—Ill-defined disorder—Dexamethasone—psoriatic arthritis	0.000916	0.00148	CcSEcCtD
Paricalcitol—Ill-defined disorder—Betamethasone—psoriatic arthritis	0.000916	0.00148	CcSEcCtD
Paricalcitol—Discomfort—Triamcinolone—psoriatic arthritis	0.000915	0.00148	CcSEcCtD
Paricalcitol—Discomfort—Methylprednisolone—psoriatic arthritis	0.000913	0.00148	CcSEcCtD
Paricalcitol—Dry mouth—Triamcinolone—psoriatic arthritis	0.000906	0.00146	CcSEcCtD
Paricalcitol—Angioedema—Betamethasone—psoriatic arthritis	0.000902	0.00146	CcSEcCtD
Paricalcitol—Angioedema—Dexamethasone—psoriatic arthritis	0.000902	0.00146	CcSEcCtD
Paricalcitol—Angiopathy—Prednisone—psoriatic arthritis	0.000896	0.00145	CcSEcCtD
Paricalcitol—Conjunctivitis—Methotrexate—psoriatic arthritis	0.000894	0.00145	CcSEcCtD
Paricalcitol—Confusional state—Methylprednisolone—psoriatic arthritis	0.000893	0.00144	CcSEcCtD
Paricalcitol—Immune system disorder—Prednisone—psoriatic arthritis	0.000892	0.00144	CcSEcCtD
Paricalcitol—Malaise—Dexamethasone—psoriatic arthritis	0.00089	0.00144	CcSEcCtD
Paricalcitol—Malaise—Betamethasone—psoriatic arthritis	0.00089	0.00144	CcSEcCtD
Paricalcitol—Oedema—Triamcinolone—psoriatic arthritis	0.000888	0.00144	CcSEcCtD
Paricalcitol—Vertigo—Dexamethasone—psoriatic arthritis	0.000887	0.00143	CcSEcCtD
Paricalcitol—Vertigo—Betamethasone—psoriatic arthritis	0.000887	0.00143	CcSEcCtD
Paricalcitol—Syncope—Betamethasone—psoriatic arthritis	0.000885	0.00143	CcSEcCtD
Paricalcitol—Syncope—Dexamethasone—psoriatic arthritis	0.000885	0.00143	CcSEcCtD
Paricalcitol—Arrhythmia—Prednisone—psoriatic arthritis	0.000882	0.00143	CcSEcCtD
Paricalcitol—Infection—Triamcinolone—psoriatic arthritis	0.000882	0.00143	CcSEcCtD
Paricalcitol—Sweating—Methotrexate—psoriatic arthritis	0.000882	0.00143	CcSEcCtD
Paricalcitol—Infection—Methylprednisolone—psoriatic arthritis	0.00088	0.00142	CcSEcCtD
Paricalcitol—Shock—Triamcinolone—psoriatic arthritis	0.000874	0.00141	CcSEcCtD
Paricalcitol—Insomnia—Prednisolone—psoriatic arthritis	0.000873	0.00141	CcSEcCtD
Paricalcitol—Alopecia—Prednisone—psoriatic arthritis	0.000873	0.00141	CcSEcCtD
Paricalcitol—Shock—Methylprednisolone—psoriatic arthritis	0.000872	0.00141	CcSEcCtD
Paricalcitol—Nervous system disorder—Methylprednisolone—psoriatic arthritis	0.000869	0.00141	CcSEcCtD
Paricalcitol—Loss of consciousness—Betamethasone—psoriatic arthritis	0.000868	0.0014	CcSEcCtD
Paricalcitol—Loss of consciousness—Dexamethasone—psoriatic arthritis	0.000868	0.0014	CcSEcCtD
Paricalcitol—Epistaxis—Methotrexate—psoriatic arthritis	0.000867	0.0014	CcSEcCtD
Paricalcitol—Paraesthesia—Prednisolone—psoriatic arthritis	0.000867	0.0014	CcSEcCtD
Paricalcitol—Mental disorder—Prednisone—psoriatic arthritis	0.000865	0.0014	CcSEcCtD
Paricalcitol—Skin disorder—Methylprednisolone—psoriatic arthritis	0.000861	0.00139	CcSEcCtD
Paricalcitol—Malnutrition—Prednisone—psoriatic arthritis	0.00086	0.00139	CcSEcCtD
Paricalcitol—Hyperhidrosis—Triamcinolone—psoriatic arthritis	0.000858	0.00139	CcSEcCtD
Paricalcitol—Hyperhidrosis—Methylprednisolone—psoriatic arthritis	0.000857	0.00139	CcSEcCtD
Paricalcitol—Hypertension—Dexamethasone—psoriatic arthritis	0.000852	0.00138	CcSEcCtD
Paricalcitol—Hypertension—Betamethasone—psoriatic arthritis	0.000852	0.00138	CcSEcCtD
Paricalcitol—Myalgia—Betamethasone—psoriatic arthritis	0.000841	0.00136	CcSEcCtD
Paricalcitol—Myalgia—Dexamethasone—psoriatic arthritis	0.000841	0.00136	CcSEcCtD
Paricalcitol—Anxiety—Dexamethasone—psoriatic arthritis	0.000838	0.00135	CcSEcCtD
Paricalcitol—Anxiety—Betamethasone—psoriatic arthritis	0.000838	0.00135	CcSEcCtD
Paricalcitol—Discomfort—Betamethasone—psoriatic arthritis	0.00083	0.00134	CcSEcCtD
Paricalcitol—Discomfort—Dexamethasone—psoriatic arthritis	0.00083	0.00134	CcSEcCtD
Paricalcitol—Hypotension—Methylprednisolone—psoriatic arthritis	0.000828	0.00134	CcSEcCtD
Paricalcitol—Pain—Prednisolone—psoriatic arthritis	0.000826	0.00134	CcSEcCtD
Paricalcitol—Pharyngitis—Methotrexate—psoriatic arthritis	0.000819	0.00132	CcSEcCtD
Paricalcitol—Urinary tract disorder—Methotrexate—psoriatic arthritis	0.000815	0.00132	CcSEcCtD
Paricalcitol—Urethral disorder—Methotrexate—psoriatic arthritis	0.000809	0.00131	CcSEcCtD
Paricalcitol—Musculoskeletal discomfort—Triamcinolone—psoriatic arthritis	0.000809	0.00131	CcSEcCtD
Paricalcitol—Musculoskeletal discomfort—Methylprednisolone—psoriatic arthritis	0.000807	0.00131	CcSEcCtD
Paricalcitol—Oedema—Betamethasone—psoriatic arthritis	0.000806	0.0013	CcSEcCtD
Paricalcitol—Oedema—Dexamethasone—psoriatic arthritis	0.000806	0.0013	CcSEcCtD
Paricalcitol—Insomnia—Triamcinolone—psoriatic arthritis	0.000803	0.0013	CcSEcCtD
Paricalcitol—Insomnia—Methylprednisolone—psoriatic arthritis	0.000801	0.0013	CcSEcCtD
Paricalcitol—Infection—Dexamethasone—psoriatic arthritis	0.000801	0.00129	CcSEcCtD
Paricalcitol—Infection—Betamethasone—psoriatic arthritis	0.000801	0.00129	CcSEcCtD
Paricalcitol—Ill-defined disorder—Prednisone—psoriatic arthritis	0.000798	0.00129	CcSEcCtD
Paricalcitol—Paraesthesia—Triamcinolone—psoriatic arthritis	0.000797	0.00129	CcSEcCtD
Paricalcitol—Feeling abnormal—Prednisolone—psoriatic arthritis	0.000796	0.00129	CcSEcCtD
Paricalcitol—Paraesthesia—Methylprednisolone—psoriatic arthritis	0.000796	0.00129	CcSEcCtD
Paricalcitol—Anaemia—Prednisone—psoriatic arthritis	0.000795	0.00128	CcSEcCtD
Paricalcitol—Shock—Dexamethasone—psoriatic arthritis	0.000793	0.00128	CcSEcCtD
Paricalcitol—Shock—Betamethasone—psoriatic arthritis	0.000793	0.00128	CcSEcCtD
Paricalcitol—Dyspnoea—Triamcinolone—psoriatic arthritis	0.000792	0.00128	CcSEcCtD
Paricalcitol—Nervous system disorder—Dexamethasone—psoriatic arthritis	0.00079	0.00128	CcSEcCtD
Paricalcitol—Nervous system disorder—Betamethasone—psoriatic arthritis	0.00079	0.00128	CcSEcCtD
Paricalcitol—Agitation—Prednisone—psoriatic arthritis	0.00079	0.00128	CcSEcCtD
Paricalcitol—Angioedema—Prednisone—psoriatic arthritis	0.000786	0.00127	CcSEcCtD
Paricalcitol—Dyspepsia—Triamcinolone—psoriatic arthritis	0.000782	0.00126	CcSEcCtD
Paricalcitol—Dyspepsia—Methylprednisolone—psoriatic arthritis	0.00078	0.00126	CcSEcCtD
Paricalcitol—Hyperhidrosis—Dexamethasone—psoriatic arthritis	0.000779	0.00126	CcSEcCtD
Paricalcitol—Hyperhidrosis—Betamethasone—psoriatic arthritis	0.000779	0.00126	CcSEcCtD
Paricalcitol—Malaise—Prednisone—psoriatic arthritis	0.000775	0.00125	CcSEcCtD
Paricalcitol—Vertigo—Prednisone—psoriatic arthritis	0.000772	0.00125	CcSEcCtD
Paricalcitol—Eye disorder—Methotrexate—psoriatic arthritis	0.000771	0.00125	CcSEcCtD
Paricalcitol—Syncope—Prednisone—psoriatic arthritis	0.000771	0.00125	CcSEcCtD
Paricalcitol—Anorexia—Dexamethasone—psoriatic arthritis	0.000768	0.00124	CcSEcCtD
Paricalcitol—Anorexia—Betamethasone—psoriatic arthritis	0.000768	0.00124	CcSEcCtD
Paricalcitol—Urticaria—Prednisolone—psoriatic arthritis	0.000767	0.00124	CcSEcCtD
Paricalcitol—Cardiac disorder—Methotrexate—psoriatic arthritis	0.000766	0.00124	CcSEcCtD
Paricalcitol—Fatigue—Triamcinolone—psoriatic arthritis	0.000766	0.00124	CcSEcCtD
Paricalcitol—Fatigue—Methylprednisolone—psoriatic arthritis	0.000764	0.00124	CcSEcCtD
Paricalcitol—Pain—Triamcinolone—psoriatic arthritis	0.000759	0.00123	CcSEcCtD
Paricalcitol—Loss of consciousness—Prednisone—psoriatic arthritis	0.000756	0.00122	CcSEcCtD
Paricalcitol—Hypotension—Dexamethasone—psoriatic arthritis	0.000753	0.00122	CcSEcCtD
Paricalcitol—Hypotension—Betamethasone—psoriatic arthritis	0.000753	0.00122	CcSEcCtD
Paricalcitol—Angiopathy—Methotrexate—psoriatic arthritis	0.000749	0.00121	CcSEcCtD
Paricalcitol—Immune system disorder—Methotrexate—psoriatic arthritis	0.000746	0.00121	CcSEcCtD
Paricalcitol—Mediastinal disorder—Methotrexate—psoriatic arthritis	0.000744	0.0012	CcSEcCtD
Paricalcitol—Hypertension—Prednisone—psoriatic arthritis	0.000742	0.0012	CcSEcCtD
Paricalcitol—Chills—Methotrexate—psoriatic arthritis	0.000741	0.0012	CcSEcCtD
Paricalcitol—Musculoskeletal discomfort—Betamethasone—psoriatic arthritis	0.000734	0.00119	CcSEcCtD
Paricalcitol—Musculoskeletal discomfort—Dexamethasone—psoriatic arthritis	0.000734	0.00119	CcSEcCtD
Paricalcitol—Myalgia—Prednisone—psoriatic arthritis	0.000732	0.00118	CcSEcCtD
Paricalcitol—Arthralgia—Prednisone—psoriatic arthritis	0.000732	0.00118	CcSEcCtD
Paricalcitol—Feeling abnormal—Triamcinolone—psoriatic arthritis	0.000732	0.00118	CcSEcCtD
Paricalcitol—Feeling abnormal—Methylprednisolone—psoriatic arthritis	0.00073	0.00118	CcSEcCtD
Paricalcitol—Anxiety—Prednisone—psoriatic arthritis	0.000729	0.00118	CcSEcCtD
Paricalcitol—Alopecia—Methotrexate—psoriatic arthritis	0.000729	0.00118	CcSEcCtD
Paricalcitol—Insomnia—Dexamethasone—psoriatic arthritis	0.000729	0.00118	CcSEcCtD
Paricalcitol—Insomnia—Betamethasone—psoriatic arthritis	0.000729	0.00118	CcSEcCtD
Paricalcitol—Unspecified disorder of skin and subcutaneous tissue—Prednisone—psoriatic arthritis	0.000727	0.00118	CcSEcCtD
Paricalcitol—Gastrointestinal pain—Methylprednisolone—psoriatic arthritis	0.000725	0.00117	CcSEcCtD
Paricalcitol—Paraesthesia—Dexamethasone—psoriatic arthritis	0.000724	0.00117	CcSEcCtD
Paricalcitol—Paraesthesia—Betamethasone—psoriatic arthritis	0.000724	0.00117	CcSEcCtD
Paricalcitol—Discomfort—Prednisone—psoriatic arthritis	0.000723	0.00117	CcSEcCtD
Paricalcitol—Mental disorder—Methotrexate—psoriatic arthritis	0.000723	0.00117	CcSEcCtD
Paricalcitol—Malnutrition—Methotrexate—psoriatic arthritis	0.000719	0.00116	CcSEcCtD
Paricalcitol—Hypersensitivity—Prednisolone—psoriatic arthritis	0.000711	0.00115	CcSEcCtD
Paricalcitol—Dyspepsia—Dexamethasone—psoriatic arthritis	0.000709	0.00115	CcSEcCtD
Paricalcitol—Dyspepsia—Betamethasone—psoriatic arthritis	0.000709	0.00115	CcSEcCtD
Paricalcitol—Urticaria—Triamcinolone—psoriatic arthritis	0.000705	0.00114	CcSEcCtD
Paricalcitol—Urticaria—Methylprednisolone—psoriatic arthritis	0.000704	0.00114	CcSEcCtD
Paricalcitol—Dysgeusia—Methotrexate—psoriatic arthritis	0.000704	0.00114	CcSEcCtD
Paricalcitol—Body temperature increased—Triamcinolone—psoriatic arthritis	0.000702	0.00114	CcSEcCtD
Paricalcitol—Oedema—Prednisone—psoriatic arthritis	0.000702	0.00113	CcSEcCtD
Paricalcitol—Abdominal pain—Methylprednisolone—psoriatic arthritis	0.0007	0.00113	CcSEcCtD
Paricalcitol—Decreased appetite—Dexamethasone—psoriatic arthritis	0.0007	0.00113	CcSEcCtD
Paricalcitol—Decreased appetite—Betamethasone—psoriatic arthritis	0.0007	0.00113	CcSEcCtD
Paricalcitol—Infection—Prednisone—psoriatic arthritis	0.000697	0.00113	CcSEcCtD
Paricalcitol—Gastrointestinal disorder—Dexamethasone—psoriatic arthritis	0.000696	0.00112	CcSEcCtD
Paricalcitol—Gastrointestinal disorder—Betamethasone—psoriatic arthritis	0.000696	0.00112	CcSEcCtD
Paricalcitol—Back pain—Methotrexate—psoriatic arthritis	0.000695	0.00112	CcSEcCtD
Paricalcitol—Fatigue—Dexamethasone—psoriatic arthritis	0.000695	0.00112	CcSEcCtD
Paricalcitol—Fatigue—Betamethasone—psoriatic arthritis	0.000695	0.00112	CcSEcCtD
Paricalcitol—Shock—Prednisone—psoriatic arthritis	0.00069	0.00112	CcSEcCtD
Paricalcitol—Pain—Dexamethasone—psoriatic arthritis	0.000689	0.00111	CcSEcCtD
Paricalcitol—Pain—Betamethasone—psoriatic arthritis	0.000689	0.00111	CcSEcCtD
Paricalcitol—Nervous system disorder—Prednisone—psoriatic arthritis	0.000688	0.00111	CcSEcCtD
Paricalcitol—Skin disorder—Prednisone—psoriatic arthritis	0.000682	0.0011	CcSEcCtD
Paricalcitol—Hyperhidrosis—Prednisone—psoriatic arthritis	0.000678	0.0011	CcSEcCtD
Paricalcitol—Anorexia—Prednisone—psoriatic arthritis	0.000669	0.00108	CcSEcCtD
Paricalcitol—Ill-defined disorder—Methotrexate—psoriatic arthritis	0.000667	0.00108	CcSEcCtD
Paricalcitol—Anaemia—Methotrexate—psoriatic arthritis	0.000664	0.00107	CcSEcCtD
Paricalcitol—Feeling abnormal—Betamethasone—psoriatic arthritis	0.000664	0.00107	CcSEcCtD
Paricalcitol—Feeling abnormal—Dexamethasone—psoriatic arthritis	0.000664	0.00107	CcSEcCtD
Paricalcitol—Gastrointestinal pain—Betamethasone—psoriatic arthritis	0.000659	0.00107	CcSEcCtD
Paricalcitol—Gastrointestinal pain—Dexamethasone—psoriatic arthritis	0.000659	0.00107	CcSEcCtD
Paricalcitol—Hypersensitivity—Triamcinolone—psoriatic arthritis	0.000654	0.00106	CcSEcCtD
Paricalcitol—Hypersensitivity—Methylprednisolone—psoriatic arthritis	0.000653	0.00106	CcSEcCtD
Paricalcitol—Malaise—Methotrexate—psoriatic arthritis	0.000648	0.00105	CcSEcCtD
Paricalcitol—Vertigo—Methotrexate—psoriatic arthritis	0.000646	0.00104	CcSEcCtD
Paricalcitol—Leukopenia—Methotrexate—psoriatic arthritis	0.000643	0.00104	CcSEcCtD
Paricalcitol—Urticaria—Dexamethasone—psoriatic arthritis	0.00064	0.00104	CcSEcCtD
Paricalcitol—Urticaria—Betamethasone—psoriatic arthritis	0.00064	0.00104	CcSEcCtD
Paricalcitol—Musculoskeletal discomfort—Prednisone—psoriatic arthritis	0.000639	0.00103	CcSEcCtD
Paricalcitol—Dizziness—Prednisolone—psoriatic arthritis	0.000639	0.00103	CcSEcCtD
Paricalcitol—Asthenia—Triamcinolone—psoriatic arthritis	0.000637	0.00103	CcSEcCtD
Paricalcitol—Body temperature increased—Dexamethasone—psoriatic arthritis	0.000637	0.00103	CcSEcCtD
Paricalcitol—Body temperature increased—Betamethasone—psoriatic arthritis	0.000637	0.00103	CcSEcCtD
Paricalcitol—Abdominal pain—Betamethasone—psoriatic arthritis	0.000637	0.00103	CcSEcCtD
Paricalcitol—Abdominal pain—Dexamethasone—psoriatic arthritis	0.000637	0.00103	CcSEcCtD
Paricalcitol—Asthenia—Methylprednisolone—psoriatic arthritis	0.000636	0.00103	CcSEcCtD
Paricalcitol—Insomnia—Prednisone—psoriatic arthritis	0.000635	0.00103	CcSEcCtD
Paricalcitol—Paraesthesia—Prednisone—psoriatic arthritis	0.00063	0.00102	CcSEcCtD
Paricalcitol—Pruritus—Triamcinolone—psoriatic arthritis	0.000628	0.00102	CcSEcCtD
Paricalcitol—Cough—Methotrexate—psoriatic arthritis	0.000627	0.00101	CcSEcCtD
Paricalcitol—Pruritus—Methylprednisolone—psoriatic arthritis	0.000627	0.00101	CcSEcCtD
Paricalcitol—Dyspepsia—Prednisone—psoriatic arthritis	0.000618	0.000999	CcSEcCtD
Paricalcitol—Chest pain—Methotrexate—psoriatic arthritis	0.000612	0.000989	CcSEcCtD
Paricalcitol—Myalgia—Methotrexate—psoriatic arthritis	0.000612	0.000989	CcSEcCtD
Paricalcitol—Arthralgia—Methotrexate—psoriatic arthritis	0.000612	0.000989	CcSEcCtD
Paricalcitol—Decreased appetite—Prednisone—psoriatic arthritis	0.00061	0.000986	CcSEcCtD
Paricalcitol—Rash—Prednisolone—psoriatic arthritis	0.000609	0.000985	CcSEcCtD
Paricalcitol—Dermatitis—Prednisolone—psoriatic arthritis	0.000608	0.000984	CcSEcCtD
Paricalcitol—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—psoriatic arthritis	0.000608	0.000982	CcSEcCtD
Paricalcitol—Diarrhoea—Methylprednisolone—psoriatic arthritis	0.000606	0.00098	CcSEcCtD
Paricalcitol—Fatigue—Prednisone—psoriatic arthritis	0.000605	0.000978	CcSEcCtD
Paricalcitol—Headache—Prednisolone—psoriatic arthritis	0.000605	0.000978	CcSEcCtD
Paricalcitol—Discomfort—Methotrexate—psoriatic arthritis	0.000604	0.000977	CcSEcCtD
Paricalcitol—Constipation—Prednisone—psoriatic arthritis	0.0006	0.00097	CcSEcCtD
Paricalcitol—Confusional state—Methotrexate—psoriatic arthritis	0.000591	0.000956	CcSEcCtD
Paricalcitol—Dizziness—Triamcinolone—psoriatic arthritis	0.000587	0.00095	CcSEcCtD
Paricalcitol—Dizziness—Methylprednisolone—psoriatic arthritis	0.000586	0.000947	CcSEcCtD
Paricalcitol—Infection—Methotrexate—psoriatic arthritis	0.000583	0.000942	CcSEcCtD
Paricalcitol—Feeling abnormal—Prednisone—psoriatic arthritis	0.000578	0.000935	CcSEcCtD
Paricalcitol—Asthenia—Dexamethasone—psoriatic arthritis	0.000578	0.000935	CcSEcCtD
Paricalcitol—Asthenia—Betamethasone—psoriatic arthritis	0.000578	0.000935	CcSEcCtD
Paricalcitol—Nervous system disorder—Methotrexate—psoriatic arthritis	0.000575	0.00093	CcSEcCtD
Paricalcitol—Gastrointestinal pain—Prednisone—psoriatic arthritis	0.000574	0.000928	CcSEcCtD
Paricalcitol—Nausea—Prednisolone—psoriatic arthritis	0.000574	0.000927	CcSEcCtD
Paricalcitol—Pruritus—Betamethasone—psoriatic arthritis	0.00057	0.000922	CcSEcCtD
Paricalcitol—Pruritus—Dexamethasone—psoriatic arthritis	0.00057	0.000922	CcSEcCtD
Paricalcitol—Skin disorder—Methotrexate—psoriatic arthritis	0.00057	0.000921	CcSEcCtD
Paricalcitol—Hyperhidrosis—Methotrexate—psoriatic arthritis	0.000567	0.000917	CcSEcCtD
Paricalcitol—Vomiting—Triamcinolone—psoriatic arthritis	0.000565	0.000913	CcSEcCtD
Paricalcitol—Vomiting—Methylprednisolone—psoriatic arthritis	0.000563	0.000911	CcSEcCtD
Paricalcitol—Rash—Triamcinolone—psoriatic arthritis	0.00056	0.000905	CcSEcCtD
Paricalcitol—Dermatitis—Triamcinolone—psoriatic arthritis	0.000559	0.000905	CcSEcCtD
Paricalcitol—Anorexia—Methotrexate—psoriatic arthritis	0.000559	0.000904	CcSEcCtD
Paricalcitol—Rash—Methylprednisolone—psoriatic arthritis	0.000559	0.000903	CcSEcCtD
Paricalcitol—Dermatitis—Methylprednisolone—psoriatic arthritis	0.000558	0.000903	CcSEcCtD
Paricalcitol—Urticaria—Prednisone—psoriatic arthritis	0.000557	0.000901	CcSEcCtD
Paricalcitol—Headache—Triamcinolone—psoriatic arthritis	0.000556	0.0009	CcSEcCtD
Paricalcitol—Headache—Methylprednisolone—psoriatic arthritis	0.000555	0.000898	CcSEcCtD
Paricalcitol—Abdominal pain—Prednisone—psoriatic arthritis	0.000555	0.000897	CcSEcCtD
Paricalcitol—Body temperature increased—Prednisone—psoriatic arthritis	0.000555	0.000897	CcSEcCtD
Paricalcitol—Diarrhoea—Betamethasone—psoriatic arthritis	0.000551	0.000891	CcSEcCtD
Paricalcitol—Diarrhoea—Dexamethasone—psoriatic arthritis	0.000551	0.000891	CcSEcCtD
Paricalcitol—Hypotension—Methotrexate—psoriatic arthritis	0.000548	0.000886	CcSEcCtD
Paricalcitol—Musculoskeletal discomfort—Methotrexate—psoriatic arthritis	0.000534	0.000864	CcSEcCtD
Paricalcitol—Dizziness—Dexamethasone—psoriatic arthritis	0.000533	0.000862	CcSEcCtD
Paricalcitol—Dizziness—Betamethasone—psoriatic arthritis	0.000533	0.000862	CcSEcCtD
Paricalcitol—Insomnia—Methotrexate—psoriatic arthritis	0.00053	0.000858	CcSEcCtD
Paricalcitol—Nausea—Triamcinolone—psoriatic arthritis	0.000527	0.000853	CcSEcCtD
Paricalcitol—Paraesthesia—Methotrexate—psoriatic arthritis	0.000527	0.000851	CcSEcCtD
Paricalcitol—Nausea—Methylprednisolone—psoriatic arthritis	0.000526	0.000851	CcSEcCtD
Paricalcitol—Dyspnoea—Methotrexate—psoriatic arthritis	0.000523	0.000845	CcSEcCtD
Paricalcitol—Somnolence—Methotrexate—psoriatic arthritis	0.000521	0.000843	CcSEcCtD
Paricalcitol—Hypersensitivity—Prednisone—psoriatic arthritis	0.000517	0.000836	CcSEcCtD
Paricalcitol—Dyspepsia—Methotrexate—psoriatic arthritis	0.000516	0.000835	CcSEcCtD
Paricalcitol—Vomiting—Dexamethasone—psoriatic arthritis	0.000512	0.000828	CcSEcCtD
Paricalcitol—Vomiting—Betamethasone—psoriatic arthritis	0.000512	0.000828	CcSEcCtD
Paricalcitol—Decreased appetite—Methotrexate—psoriatic arthritis	0.00051	0.000824	CcSEcCtD
Paricalcitol—Rash—Betamethasone—psoriatic arthritis	0.000508	0.000821	CcSEcCtD
Paricalcitol—Rash—Dexamethasone—psoriatic arthritis	0.000508	0.000821	CcSEcCtD
Paricalcitol—Dermatitis—Betamethasone—psoriatic arthritis	0.000508	0.000821	CcSEcCtD
Paricalcitol—Dermatitis—Dexamethasone—psoriatic arthritis	0.000508	0.000821	CcSEcCtD
Paricalcitol—Gastrointestinal disorder—Methotrexate—psoriatic arthritis	0.000506	0.000819	CcSEcCtD
Paricalcitol—Fatigue—Methotrexate—psoriatic arthritis	0.000506	0.000818	CcSEcCtD
Paricalcitol—Headache—Dexamethasone—psoriatic arthritis	0.000505	0.000816	CcSEcCtD
Paricalcitol—Headache—Betamethasone—psoriatic arthritis	0.000505	0.000816	CcSEcCtD
Paricalcitol—Asthenia—Prednisone—psoriatic arthritis	0.000503	0.000814	CcSEcCtD
Paricalcitol—Pain—Methotrexate—psoriatic arthritis	0.000501	0.000811	CcSEcCtD
Paricalcitol—Pruritus—Prednisone—psoriatic arthritis	0.000496	0.000803	CcSEcCtD
Paricalcitol—Feeling abnormal—Methotrexate—psoriatic arthritis	0.000483	0.000781	CcSEcCtD
Paricalcitol—Diarrhoea—Prednisone—psoriatic arthritis	0.00048	0.000776	CcSEcCtD
Paricalcitol—Gastrointestinal pain—Methotrexate—psoriatic arthritis	0.00048	0.000775	CcSEcCtD
Paricalcitol—Nausea—Dexamethasone—psoriatic arthritis	0.000479	0.000774	CcSEcCtD
Paricalcitol—Nausea—Betamethasone—psoriatic arthritis	0.000479	0.000774	CcSEcCtD
Paricalcitol—Urticaria—Methotrexate—psoriatic arthritis	0.000466	0.000753	CcSEcCtD
Paricalcitol—Dizziness—Prednisone—psoriatic arthritis	0.000464	0.00075	CcSEcCtD
Paricalcitol—Abdominal pain—Methotrexate—psoriatic arthritis	0.000464	0.00075	CcSEcCtD
Paricalcitol—Body temperature increased—Methotrexate—psoriatic arthritis	0.000464	0.00075	CcSEcCtD
Paricalcitol—Vomiting—Prednisone—psoriatic arthritis	0.000446	0.000721	CcSEcCtD
Paricalcitol—Rash—Prednisone—psoriatic arthritis	0.000442	0.000715	CcSEcCtD
Paricalcitol—Dermatitis—Prednisone—psoriatic arthritis	0.000442	0.000715	CcSEcCtD
Paricalcitol—Headache—Prednisone—psoriatic arthritis	0.00044	0.000711	CcSEcCtD
Paricalcitol—Hypersensitivity—Methotrexate—psoriatic arthritis	0.000432	0.000699	CcSEcCtD
Paricalcitol—Asthenia—Methotrexate—psoriatic arthritis	0.000421	0.00068	CcSEcCtD
Paricalcitol—Nausea—Prednisone—psoriatic arthritis	0.000417	0.000674	CcSEcCtD
Paricalcitol—Pruritus—Methotrexate—psoriatic arthritis	0.000415	0.000671	CcSEcCtD
Paricalcitol—Diarrhoea—Methotrexate—psoriatic arthritis	0.000401	0.000649	CcSEcCtD
Paricalcitol—Dizziness—Methotrexate—psoriatic arthritis	0.000388	0.000627	CcSEcCtD
Paricalcitol—Vomiting—Methotrexate—psoriatic arthritis	0.000373	0.000603	CcSEcCtD
Paricalcitol—Rash—Methotrexate—psoriatic arthritis	0.00037	0.000598	CcSEcCtD
Paricalcitol—Dermatitis—Methotrexate—psoriatic arthritis	0.000369	0.000597	CcSEcCtD
Paricalcitol—Headache—Methotrexate—psoriatic arthritis	0.000367	0.000594	CcSEcCtD
Paricalcitol—Nausea—Methotrexate—psoriatic arthritis	0.000348	0.000563	CcSEcCtD
